Updated to clarify that PerkinElmer is reorganizing into separate business units, not spinning out standalone businesses. PerkinElmer said today that it’s planning to reorganize its business, creating a separate reproductive health-focused diagnostics business unit and a discovery & analytical solutions unit, effective Oct. 3. The new stand-alone diagnostics business unit will be headed by newly-assigned senior VP & […]
PerkinElmer Inc.
Massachusetts Life Sciences Center awards $25 million in tax incentives
The Massachusetts Life Science Center has doled out more than $25 million to 25 life science companies who pledged to create new jobs in its latest round of tax incentives,
Palomar, Syneron settle patent spat for $31M plus royalties | Legal News
SyntheMed and Pathfinder become Pathfinder Cell Therapy after merger | Acquisitions Roundup
Closing an agreement that’s been in the works since January, SyntheMed, Inc. (OTC:SYMD), a biomaterials company, changed its name to Pathfinder Cell Therapy, after merging with the biotechnology company.
Richard Franklin, who was President & CEO of Pathfinder, will keep his corner office and Joerg Gruber, a former director of SyntheMed will serve as chairman of the board for the newly created company.
Report: Consolidation ahead for medical device sector | Acquisitions Roundup
Impending federal excise taxes, downward pricing pressure and declining volumes of big-ticket procedures constitute a triple threat that will drive the medical device industry to consolidate, according to a PricewaterhouseCoopers report.
The total value of health care deals over the past 12 months rose 40 percent, according to the consulting giant’s “U.S. Mid-Year M&A Outlook.” That trend is likely to continue, the report predicts.
PerkinElmer Q1 profits inch downward despite 14 percent sales increase | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Cardinal Health lands $1 billion military contract | Deals roundup
Cardinal Health 200 Inc. won a $1.02 billion contract from Uncle Sam.
The two-year deal announced yesterday calls for the company to provide medical surgical supplies to the Army, Navy, Air Force and Marine Corps.
The McGaw Park, Ill.-based company is a subsidiary of health care and laboratory products and services giant Cardinal Health Inc. (NYSE:CAH).
PerkinElmer drops $220 million on a pair of software companies
PerkinElmer Inc. (NYSE:PKI) made announcements on two software firm acquisition deals intended to expand its offerings for the pharmaceutical industry.
The Waltham, Mass.-based life science and health IT firm said it will spend about $220 million as it closed its deal on R&D software company ArtusLabs Inc. and announced an agreement to acquire CambridgeSoft Corp.
PerkinElmer says “No sale”
PerkinElmer Inc. (NYSE:PKI) shares are now down more than 4 percent today, falling $1.12 to $26.60 after the diagnostics giant flatly denied takeover speculation.
PerkinElmer buys out German molecular diagnostics firm | Acquisitions roundup
Here’s a roundup of companies announcing mergers, acquisitions and divestitures.
Life rides sales growth to 45 percent profit increase | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days: